“Il 2025 sarà ricordato come l’anno in cui abbiamo accettato che le guerre potessero essere governate da regole diverse, applicate a seconda del contesto, degli alleati, della geografia morale di chi guarda”. @mannocchia https://t.co/NoX1PxtVeN

📢 Re-irradiation for prostate cancer relapse after prior radiotherapy is safe,and effective. A study on behalf of Italian association of radiotherapy and clinical oncology (AIRO) 🔬 54-month fup ✅Low rates of severe toxicity 📈 BRFS: 34 months 🔗

❓ESTRO & EORTC proposed a classification to standardize reirradiation. But does it predict outcomes or toxicity? 🫁☢️ We applied the classification in thoracic reirradiation for NSCLC. Here’s what we found. 🧵

🇵🇸🇮🇱 Comunque la pensiate sul conflitto, lasciare un'intera popolazione assediata senza cibo e aiuti umanitari è un crimine di guerra. A mio parere, uno dei peggiori. Dopo il collasso del cessate il fuoco, da DUE mesi non entra più alcun aiuto nella Striscia. Terribile.

Remember the misleading press reports about "brutal" #radonc after PROSPECT ? This is what modern radiotherapy can achieve for elderly breast cancer patients! 👉 "Endocrine Tx was associated with a greater reduction in HRQOL compared with RT at 24 mo" 👉 oncological data awaited

Presented at #SABCS24: Interim results from the EUROPA trial: Single-modality #endocrinetherapy vs #radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early #breastcancer https://t.co/ay6evWBQBG

Must read clinical trials in the field of #SBRT 2024 Please complement the list, to allow us staying up-to-date !

(1/4) Check out our latest editorial in @RadiotherapyOn1 Green J, where we dive into the nuances of oligomets! Link: https://t.co/N6b7UlzmOC In the clinic, we often describe tumors as indolent vs. rapidly progressing. But we still lack a solid metric to quantify this.

Apalutamide and SBRT for low-burden, metastatic, hormone-sensitive #ProstateCancer #PERSIAN. Presentation by @GiulioFrancoli1 @AOUCareggi. #GU24 written coverage by @RKSayyid @UofT > https://t.co/u888XAKtbZ @ASCO

Quality of Life After radical treatment for MIBc (cistectomy +/-neobladder vs bladder sparing approach): a systematic review #ASCOGU23,@dicataldovanes1,@Atem84,@isteddos,@GabSimontacchi,@Icro_Meattini https://t.co/8HbuzHweve

A true honor having accepted this challenge among great Friends and Colleagues! @ESTRO_RT #radonc #medphys #OncoAlert #breastcancer @OncoAlert @ASTRO_org @UNI_FIRENZE @AOUCareggi

🚨Hot off the press @JCO_ASCO: For decades we have been offering RT omission for early #bcsm patients, here we discuss how tides have changed and its time to omit hormonal therapy and treat with RT instead @TaghianAlphonse @MGHBreastOnc @LurieCancer

The notion of “probability” is both familiar (we use it), and mysterious (we would typically struggle to define it). Here is a 🧵 to remove the mystery and make the meaning of “probability” more intuitive.

Have a look! Updates on the APBI-IMRT-Florence trial (NCT02104895) technique: from the IMRT trial to the VMAT clinical practice @LiviaMarrazzo @GabSimontacchi (free link for 50 days) #OncoAlert #OncoAlert #radonc #breastcancer

The University of Florence, Radiation Oncology Unit crew finally live, again #ESTRO2022 @ESTRO_RT @UNI_FIRENZE @AOUCareggi @OncoAlert #OncoAlert #wearebackagain #radonc

Early results from PSICHE trial showed that macroscopic disease is detected in a significant percentage of patients affected by early BR.@dicataldovanes1,@LpCiccone ,@Atem84,@GabSimontacchi,#ESTRO2022

Stereotactic salvage radioterapy for macroscopic prostate bed recurrence showed comparable BRFS rate and lower tox. If compared to standard treatment. @dicataldovanes1,@GabSimontacchi,@LpCiccone,@GiuliaMarvaso84,@Atem84,@ALESSIOBRUNI10 https://t.co/CmzzWKBlx0

Ma è possibile che qualcuno (con tesi stregonesche) possa tenere in scacco il diritto costituzionale alla salute dell’80% degli italiani? Le colonne arancioni di ospedalizzazioni e terapie intensive over 40 (dati ISS al 26.12) urlano che ora veramente BASTA! #ObbligoVaccinale

Fallimento della patente. Tra chi ha incidenti in macchina i patentati sono mille volte più dei non patentati. Però, se fate caso, questo è anche fallimento della scuola. O dell’onestà, dipende dai casi.